$4.080
+0.324 (+7.94%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PRLD por análisis de gráficos similares
Alphio's PRLD stock price prediction model matches the current Prelude Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.09 (+0.35%). The 1-week path is $4.03 (-1.24%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Prelude Therapeutics Inc?
Prelude Therapeutics Inc is a good buy right now due to its current price of $3.84, which is significantly below the analyst price target of $12, indicating a potential upside of over 200%. Additionally, the stock has shown a year-to-date change of +40.66% and a one-year change of +118.18%, reflecting strong momentum. The main risk is the negative earnings per share (EPS) of -0.14 expected for the next quarter, which indicates ongoing financial challenges.
PRLD cerró en $4.08 el Wednesday, tras subir +7.94%
Prelude Therapeutics Inc (PRLD) last closed at $4.0799999, gaining +7.94%. These facts feed the 1-day and 1-week PRLD price prediction above.
Factores de la previsión
Los factores de la previsión de Prelude Therapeutics Inc (PRLD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PRLD, ordenadas por similitud.
Análisis de estacionalidad de PRLD
Historically the probability of a positive November return for PRLD is 50.00%. August offers the highest probability of a positive month at 71.88%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PRLD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.76 | $0.83 | $0.88 | -79.62% |
| Dec 2026 | $0.93 | $0.97 | $1.00 | -76.18% |
En 2026, se proyecta que Prelude Therapeutics Inc (PRLD) oscile entre $0.76 y $1.00.
Previsión mensual de Prelude Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.83, con un mínimo de $0.76 y un máximo de $0.88.
En Dec de 2026, se proyecta que Prelude Therapeutics Inc promedie $0.97, con un mínimo de $0.93 y un máximo de $1.00.
Artículos relacionados
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.